$MTNB
Matinas BioPharma Holdings, Inc.
XASE•Health Care•Pharmaceutical Preparations
$0.160
▼-1.60%-$0.003
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMatinas BioPharma Holdings, Inc.
XASE•Health Care•Pharmaceutical Preparations
Why is MTNB down today? It is at $0.160 (-1.60%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MTNB spikes, and full due diligence on MTNB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MTNB 10 times in the last 30 days. Create a free account to track $MTNB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MTNB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MTNB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing8-KOther Material EventSep 16, 2026 · 2 days agoFrom the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Stern Adam K Beneficial Owner (10%) | Other | 975K 6.6% of company | added 100% | 1.20M | $341K at $0.350 | Jul 10, 26 |
Stern Adam K Beneficial Owner (10%) | Other | 92K 0.6% of company | added 100% | 113K | $59K at $0.640 | Oct 31, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MTNB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MTNB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MTNB last traded at $0.160, down 1.60% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Matinas BioPharma Holdings, Inc. (MTNB) is next expected to report earnings on Monday, November 9, 2026, about 51 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MTNB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MTNB 10 times in the last 30 days.
MTNB (Matinas BioPharma Holdings, Inc.) trades on XASE, with a market cap of about $2M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MTNB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MTNB discussion
Sign in to ask a question or join the discussion.